Corton Capital Inc. Axogen, Inc. Transaction History
Corton Capital Inc.
- $168 Million
- Q4 2024
A detailed history of Corton Capital Inc. transactions in Axogen, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 15,600 shares of AXGN stock, worth $313,716. This represents 0.15% of its overall portfolio holdings.
Number of Shares
15,600
Previous 26,588
41.33%
Holding current value
$313,716
Previous $372,000
30.91%
% of portfolio
0.15%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$90.6 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$65.3 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$59.4 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$48.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$48.8 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $850M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...